Interstitial

Infliximab, a tumor necrosis factor alpha (TNF-α) inhibitor, is recommended in selected cases of pulmonary sarcoidosis. Although infectious complications are well recognized, non-infectious pulmonary toxicity is less frequently reported. We describe the case of a […]